Publications du GEMO

2023

Weekly Adaptive Radiotherapy vs Standard Intensity-Modulated Radiotherapy for Improving Salivary Function in Patients With Head and Neck Cancer. A Phase 3 Randomized Clinical Trial

Castelli J, Thariat J, Benezery K, Hasbini A, Gery B, Berger A, Liem X, Guihard S, Chapet S, Thureau S, Auberdiac P, Pommier P, Ruffier A, Perrier L, Devillers A, Campillo-Gimenez B, de Crevoisier R.

Journal: JAMA Oncol.

Année: Jun 2023

Volume: e231352

https://doi.org/10.1001/jamaoncol.2023.1352

Hypofractionated radiotherapy for invasive squamous cell carcinoma of the scalp in the elderly: Efficacy and tolerance, preliminary results

Jacques J, Renard S, Demogeot N, Faivre JC, Peiffert D.

Journal: Cancer Radiother.

Année: Jun 2023

Volume: 27(4):290-295

https://doi.org/10.1016/j.canrad.2023.01.003

Zoledronate and osteonecrosis of the jaw in osteoporosis: incidence and risk factors. Analysis of the French Pharmacovigilance Database

Amigues C , Fresse A , Roux CH , Gauthier S , Vieillard MH , Drici MD , Breuil V; French Network of Pharmacovigilance Centers.

Journal: Joint Bone Spine .

Anneé: June 2023;

Volume: 105599.

Online ahead of print.

https://doi.org/10.1016/j.jbspin.2023.105599

Clinical Applications and Controversies of Whole-Body MRI: AJR Expert Panel Narrative Review

Ahlawat S, Debs P, Amini B, Lecouvet FE, Omoumi P, Wessell DE. AJR Am J Roentgenol

Journal: AJR

Année: Apr 2023

Volume: 220(4):463-475

https://doi.org/10.2214/AJR.22.28229

Engineering of a Bispecific Nanofitin with Immune Checkpoint Inhibitory Activity Conditioned by the Cross-Arm Binding to EGFR and PDL1

Jacquot P, Muñoz-Garcia J, Fleury M, Cochonneau D, Gaussin R, Enouf E, Roze C, Ollivier E, Cinier M, Heymann D.

Journal: Biomolecules.

Année: Mar 2023

Vomume: 13(4):636

http://doi.org/10.3390/biom13040636

Quantitative MRI to Characterize Hypoxic Tumors in Comparison to FMISO PET/CT for Radiotherapy in Oropharynx Cancers

Gouel P, Callonnec F, Obongo-Anga FR, Bohn P, Lévêque E, Gensanne D, Hapdey S, Modzelewski R, Vera P, Thureau S.

Journal: Cancers (Basel).

Année: Mar 2023 Mar

Volume:15(6):1918.

https://doi.org/10.3390/cancers15061918

Could conventionally fractionated radiation therapy coupled with stereotactic body radiation therapy improve local control in bone oligometastases?

Py JF, Salleron J, Vogin G, Courrech F, Teixeira P, Colnat-Coulbois S, Baumard F, Thureau S, Supiot S, Peiffert D, Oldrini G, Faivre JC.

Journal: Cancer Radiother.

Année: Feb 2023

Volume: 27(1):1-10

https://doi.org/10.1016/j.canrad.2022.03.002

Advances in osteosarcoma

Panez-Toro I, Muñoz-García J, Vargas-Franco JW, Renodon-Cornière A, Heymann MF, Lézot F, Heymann D.

Curr Osteoporosis Rep,

in press

2021

Osteonecrosis of the Jaw and Antiresorptive Agents in Benign and Malignant Diseases: A Critical Review Organized by the ECTS

Anastasilakis AD, Pepe J, Napoli N, Palermo A, Magopoulos C, Khan AA, Zillikens MC, Body JJ

Journal: The Journal of Clinical Endocrinology & Metabolism
Année: Décembre 2021
 

https://doi.org/10.1210/clinem/dgab888